These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 880785

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Therapy of hepatic diseases in ambulatory medicine. Multicenter studies].
    Martines G, Mingrino GC, Cagnetta G, Copponi V.
    Clin Ter; 1980 Jan 15; 92(1):33-58. PubMed ID: 7449307
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
    Carrescia O, Benelli L, Saraceni F, Braga PC, Cagnetta G, Copponi V.
    Clin Ter; 1980 Oct 31; 95(2):157-64. PubMed ID: 7471652
    [No Abstract] [Full Text] [Related]

  • 11. The effects of silybin on experimental phalloidine poisoning.
    Choppin J, Desplaces A.
    Arzneimittelforschung; 1978 Oct 31; 28(4):636-41. PubMed ID: 581940
    [Abstract] [Full Text] [Related]

  • 12. [Results of tests of the hepatoprotective effect of silymarin in experimental animals].
    Siblíková O, Trcka V, Vakocová H, Tichý M.
    Cas Lek Cesk; 1985 Feb 08; 124(6):165-9. PubMed ID: 3971403
    [No Abstract] [Full Text] [Related]

  • 13. [The antihepatotoxic effect of silymarin on liver damage in rats induced by carbon tetrachloride, d-galactosamine and allyl alcohol].
    Rauen HM, Schriewer H.
    Arzneimittelforschung; 1971 Aug 08; 21(8):1194-201. PubMed ID: 5110018
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of silymarin on experimental liver lesions.
    Barbarino F, Neumann E, Deaciuc I, Ghelberg NW, Suciu A, Cotuţiu C, Racoviţă L, Stroilă C, Nagy S, Părău N, Toader S, Brilinschi C.
    Med Interne; 1981 Aug 08; 19(4):347-57. PubMed ID: 7336095
    [Abstract] [Full Text] [Related]

  • 16. [Effect of convaflavine on functional status of liver in experimental hepatitis].
    Bezruk PI, Zborovskaia EA, Fedorova LI, Madievskiĭ IuM, Kolesnikova GS.
    Farmakol Toksikol; 1969 Aug 08; 32(1):65-8. PubMed ID: 5770318
    [No Abstract] [Full Text] [Related]

  • 17. Cytophotometric study of DNA in rabbit liver cells during experimental treatment of chronic hepatitis and liver cirrhosis.
    Leont'eva LI, Sherudilo AI, Iakobson GS.
    Tsitologiia; 1971 May 08; 13(5):664-7. PubMed ID: 5561714
    [No Abstract] [Full Text] [Related]

  • 18. [Constituents of Silybum marianum and their therapeutic use].
    Morelli I.
    Boll Chim Farm; 1978 May 08; 117(5):258-67. PubMed ID: 743375
    [No Abstract] [Full Text] [Related]

  • 19. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
    Pradhan SC, Girish C.
    Indian J Med Res; 2006 Nov 08; 124(5):491-504. PubMed ID: 17213517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.